Karyopharm therapeutics CEO Richard Paulson sells $3,346 in inventory By Investing.com
Karyopharm Therapeutics Inc. (NASDAQ:) President and CEO Richard Paulson lately offered 3,675 shares of the corporate's ...
Read moreKaryopharm Therapeutics Inc. (NASDAQ:) President and CEO Richard Paulson lately offered 3,675 shares of the corporate's ...
Read moreEliem Therapeutics, Inc.'s (NASDAQ:ELYM) Chief Accounting Officer, Emily Pimblett, has lately bought a portion of her ...
Read moreVivos Therapeutics, Inc. (VVOS) reported a optimistic shift in its monetary metrics for the second quarter ...
Read moreViking Therapeutics, Inc. (NASDAQ:VKTX) Q2 2024 Earnings Convention Name July 24, 2024 4:30 PM ET Firm ...
Read moreHerpen, the Netherlands-based Orexa, a clinical-stage pharmaceutical firm, introduced on Wednesday, January 31, that it has ...
Read moreMcDonald's french fries being ready.Daniel Acker | Bloomberg | Getty PicturesTry the businesses making headlines in ...
Read more© Reuters. FILE PHOTO: An Amgen signal is seen on the firm's workplace in South San ...
Read moreFly_dragonfly/iStock by way of Getty Photographs I knew Zevra Therapeutics (NASDAQ:ZVRA) when it was KemPharm, a ...
Read morePicture credit: Aer TherapeuticsAer Therapeutics, a biopharmaceutical spin-out firm and a collaboration between College School Dublin ...
Read moresevendeman/iStock by way of Getty Photographs Funding Abstract As we proceed to construct our allocations to ...
Read moreCopyright © 2022 Real Invest Solutions.
Copyright © 2022 Real Invest Solutions.